Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

TG Therapeutics

TG Therapeutics reported $149K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Alaunos Therapeutics Inc ZIOP:US USD 241K 1000
Ardelyx ARDX:US USD 21K 1000
Arrowhead Research ARWR:US USD 199K 0
Bayer BAYN:GR EUR 2.52B 0
Corcept Therapeutics CORT:US USD 131K 0
Curis CRIS:US USD 966K 0
Dynavax Technologies DVAX:US USD 128K 0
Infinity Pharmaceuticals INFI:US USD 89K 0
Intercept Pharmaceuticals ICPT:US USD 42K 0
J&J JNJ:US USD 3.12B 0
Novartis NOVN:VX USD 842M 48M
Novavax NVAX:US USD 871K 3K
PTC Therapeutics PTCT:US USD 73K 1000
Puma Biotechnology PBYI:US USD 5K 0
Roche Holding ROG:VX CHF 107M 0
Spectrum Pharmaceuticals SPPI:US USD 205K 2K
TG Therapeutics TGTX:US USD 149K 3K
Verastem VSTM:US USD 20K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0